RARA CRAFT DATABASE for FDA Medical Devices
510(k)K243441

FDA DEVICE FACTS

Nitrile Powder-Free Exam Gloves Tested for Use with Chemotherapy Drugs, Opioid Fentanyl Citrate, Simulated Gastric Acid (Light blue, Dark blue)

Basic Medical Technology, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJanuary 31, 2025PRODUCT CODELZA

Indications for use

The glove is a disposable device intended for medical purposes that is worn on the examiner’s hand to prevent contamination between patient and examiner. Gloves were tested for use with Chemotherapy drugs, Fentanyl and Gastric acid in accordance with ASTM D6978-05 standards Practice for assessment of Medical Glove to Permeation by chemotherapy drugs. Light Blue glove: NO. Chemotherapy drug Minimum Breakthrough Detection Time, minutes 1 Bendamustine HCl, 5 mg/ml >240 2 Bortezomib, 1 mg/ml >240 3 Busulfan, 6 mg/ml >240 4 Carboplatin, 10 mg/ml >240 5 Carmustine, 3.3 mg/ml 16.6 6 Carfilzomib, 2 mg/ml >240 7 Cetuximab (Erbitux), 2 mg/ml >240 8 Chloroquine, 50mg/ml >240 9 Cisplatin, 1 mg/ml >240 10 Cladribine, 1.0 mg/ml >240 11 Cyclophosphamide, 20 mg/ml >240 12 Cyclosporin A,100mg/ml >240 13 Cytarabine HCl, 100 mg/ml >240 14 Cytovene, 10 mg/ml >240 15 Dacarbazine, 10 mg/ml >240 16 Daunorubicin HCl, 5 mg/ml >240 17 Decitabine, 5 mg/ml >240 18 Docetaxel, 10 mg/ml >240 19 Doxorubicin HCl, 2 mg/ml >240 20 Epirubicin HCl, 2 mg/ml >240 21 Etoposide, 20 mg/ml >240 22 Fludarabine, 25 mg/ml >240 23 Fluorouracil, 50 mg/ml >240 24 Gemcitabine HCl, 38 mg/ml >240 25 Idarubicin HCl, 1 mg/ml >240 26 Ifosfamide, 50 mg/ml >240 27 Irinotecan HCl, 20 mg/ml >240 28 Mechlorethamine HCL, 1 mg/ml >240 29 Melphalan HCl, 5 mg/ml >240 30 Methotrexate, 25 mg/ml >240 31 Mitomycin-C, 0.5 mg/ml >240 32 Mitoxantrone HCl, 2 mg/ml >240 33 Oxaliplatin, 2 mg/ml >240 34 Paclitaxel, 6 mg/ml >240 35 Retrovir, 10 mg/ml >240 36 ThioTEPA, 10 mg/ml 44.9 37 Trisenox, 1 mg/ml >240 38 Vidaza (Azacitidine),25 mg/ml >240 39 Vincristine Sulfate,1 mg/ml >240 NO. Fentanyl Citrate and Gastric Acid Minimum Breakthrough Detection Time, minutes 1 Fentanyl Citrate Injection, 100mcg/2ml >240 2 Simulated Gastric Acid >240 *Please note that the following drugs have extremely low permeation times: Carmustine: 16.6 minutes, Thio Tepa: 44.9 minutes Warning: Do not use with Carmustine and Thio Tepa. Dark Blue glove: NO. Chemotherapy drug Minimum Breakthrough Detection Time, minutes 1 Bendamustine HCl, 5 mg/ml >240 2 Bortezomib, 1 mg/ml >240 3 Busulfan, 6 mg/ml >240 4 Carboplatin, 10 mg/ml >240 5 Carmustine, 3.3 mg/ml 21.5 6 Carfilzomib, 2 mg/ml >240 7 Cetuximab (Erbitux), 2 mg/ml >240 8 Chloroquine, 50mg/ml >240 9 Cisplatin, 1 mg/ml >240 10 Cladribine, 1.0 mg/ml >240 11 Cyclophosphamide, 20 mg/ml >240 12 Cyclosporin A,100mg/ml >240 13 Cytarabine HCl, 100 mg/ml >240 14 Cytovene, 10 mg/ml >240 15 Dacarbazine, 10 mg/ml >240 16 Daunorubicin HCl, 5 mg/ml >240 17 Decitabine, 5 mg/ml >240 18 Docetaxel, 10 mg/ml >240 19 Doxorubicin HCl, 2 mg/ml >240 20 Epirubicin HCl, 2 mg/ml >240 21 Etoposide, 20 mg/ml >240 22 Fludarabine, 25 mg/ml >240 23 Fluorouracil, 50 mg/ml >240 24 Gemcitabine HCl, 38 mg/ml >240 25 Idarubicin HCl, 1 mg/ml >240 26 Ifosfamide, 50 mg/ml >240 27 Irinotecan HCl, 20 mg/ml >240 28 Mechlorethamine HCL, 1 mg/ml >240 29 Melphalan HCl, 5 mg/ml >240 30 Methotrexate, 25 mg/ml >240 31 Mitomycin-C, 0.5 mg/ml >240 32 Mitoxantrone HCl, 2 mg/ml >240 33 Oxaliplatin, 2 mg/ml >240 34 Paclitaxel, 6 mg/ml >240 35 Retrovir, 10 mg/ml >240 36 ThioTEPA, 10 mg/ml 17.9 37 Trisenox, 1 mg/ml >240 38 Vidaza (Azacitidine),25 mg/ml >240 39 Vincristine Sulfate,1 mg/ml >240 NO. Fentanyl Citrate and Gastric Acid Minimum Breakthrough Detection Time, minutes 1 Fentanyl Citrate Injection, 100mcg/2ml >240 2 Simulated Gastric Acid >240 *Please note that the following drugs have extremely low permeation times: Carmustine: 21.5 minutes, Thio Tepa:17.9 minutes Warning: Do not use with Carmustine and Thio Tepa.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 1, 2026